144 related articles for article (PubMed ID: 22658981)
1. The reduction of superoxide dismutase activity is associated with the severity of neurological soft signs in patients with schizophrenia.
Raffa M; Fendri C; Ben Othmen L; Slama H; Amri M; Kerkeni A; Mechri A
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):52-6. PubMed ID: 22658981
[TBL] [Abstract][Full Text] [Related]
2. Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients.
Raffa M; Mechri A; Othman LB; Fendri C; Gaha L; Kerkeni A
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1178-83. PubMed ID: 19576938
[TBL] [Abstract][Full Text] [Related]
3. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
[TBL] [Abstract][Full Text] [Related]
4. Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings.
Ben Othmen L; Mechri A; Fendri C; Bost M; Chazot G; Gaha L; Kerkeni A
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):155-9. PubMed ID: 17804133
[TBL] [Abstract][Full Text] [Related]
5. Neurological soft signs in obsessive-compulsive disorder: the effect of co-morbid psychosis and evidence for familiality.
Peng ZW; Xu T; Miao GD; He QH; Zhao Q; Dazzan P; Chan RC
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):200-5. PubMed ID: 22735396
[TBL] [Abstract][Full Text] [Related]
6. Association between neurological soft signs and antioxidant enzyme activity in schizophrenic patients.
Miljević ČD; Nikolić-Kokić A; Blagojević D; Milovanović M; Munjiza A; Jukić MM; Pešić V; Lečić-Toševski D; Spasić MB
Psychiatry Res; 2018 Nov; 269():746-752. PubMed ID: 30273900
[TBL] [Abstract][Full Text] [Related]
7. [Neurological soft signs in early onset schizophrenia].
Bourgou Gaha S; Halayem Dhouib S; Amado I; Bouden A
Encephale; 2015 Jun; 41(3):209-14. PubMed ID: 24854724
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.
Zhang XY; Tan YL; Cao LY; Wu GY; Xu Q; Shen Y; Zhou DF
Schizophr Res; 2006 Jan; 81(2-3):291-300. PubMed ID: 16309894
[TBL] [Abstract][Full Text] [Related]
9. Adaptive response in the antioxidant defence system in the course and outcome in first-episode schizophrenia patients: a 12-months follow-up study.
Ruiz-Litago F; Seco J; Echevarría E; Martínez-Cengotitabengoa M; Gil J; Irazusta J; González-Pinto AM
Psychiatry Res; 2012 Dec; 200(2-3):218-22. PubMed ID: 22884309
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant enzyme and malondialdehyde levels in patients with social phobia.
Atmaca M; Kuloglu M; Tezcan E; Ustundag B
Psychiatry Res; 2008 May; 159(1-2):95-100. PubMed ID: 18339429
[TBL] [Abstract][Full Text] [Related]
11. Reduced antioxidant defense systems in schizophrenia and bipolar I disorder.
Raffa M; Barhoumi S; Atig F; Fendri C; Kerkeni A; Mechri A
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):371-5. PubMed ID: 22841966
[TBL] [Abstract][Full Text] [Related]
12. Neurological soft signs and brain morphology in first-episode schizophrenia.
Thomann PA; Wüstenberg T; Santos VD; Bachmann S; Essig M; Schröder J
Psychol Med; 2009 Mar; 39(3):371-9. PubMed ID: 18578894
[TBL] [Abstract][Full Text] [Related]
13. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
14. Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients.
Srivastava N; Barthwal MK; Dalal PK; Agarwal AK; Nag D; Srimal RC; Seth PK; Dikshit M
Psychopharmacology (Berl); 2001 Nov; 158(2):140-5. PubMed ID: 11702087
[TBL] [Abstract][Full Text] [Related]
15. Correlation analysis confirms differences in antioxidant defence in the blood of types I and II schizophrenic male patients treated with anti-psychotic medication.
Miljević C; Nikolić-Kokić A; Saicić ZS; Milosavljević M; Blagojević D; Tosevski DL; Jones DR; Spasić MB
Psychiatry Res; 2010 Jun; 178(1):68-72. PubMed ID: 20452039
[TBL] [Abstract][Full Text] [Related]
16. Glutathione peroxidase, reduced glutathione, superoxide dismutase and catalase in red cells of patients with hairy cell leukemia.
Arruda VR; Salles TS; Costa FF; Saad ST
Neoplasma; 1996; 43(2):99-102. PubMed ID: 8843970
[TBL] [Abstract][Full Text] [Related]
17. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
[TBL] [Abstract][Full Text] [Related]
18. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer.
Kaynar H; Meral M; Turhan H; Keles M; Celik G; Akcay F
Cancer Lett; 2005 Sep; 227(2):133-9. PubMed ID: 16112416
[TBL] [Abstract][Full Text] [Related]
19. Cerebellar substructures and neurological soft signs in first-episode schizophrenia.
Thomann PA; Roebel M; Dos Santos V; Bachmann S; Essig M; Schröder J
Psychiatry Res; 2009 Aug; 173(2):83-7. PubMed ID: 19540731
[TBL] [Abstract][Full Text] [Related]
20. Neurological soft signs and schizotypal dimensions in unaffected siblings of patients with schizophrenia.
Mechri A; Gassab L; Slama H; Gaha L; Saoud M; Krebs MO
Psychiatry Res; 2010 Jan; 175(1-2):22-6. PubMed ID: 19959242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
